Skip to main content
. 2021 Apr 29;149:e109. doi: 10.1017/S0950268821001023

Fig. 3.

Fig. 3.

Risk of secondary adverse outcomes in patients with a pending result for SARS-CoV-2 test with obesity or obesity plus one other comorbidity. (a) Risk of hospitalisation, model adjusted by sex, age and time from symptom onset to care, SLI, ageing index, afro-descendant per 100 inhabitants, indigenous language-speaking per 100 inhabitants, affiliation to health services per 100 inhabitants, members per household, hospitals per 10 000 inhabitants, hospital beds per 10 000 inhabitants. (b) Risk of IMV, model adjusted by sex, age and time from symptom onset to care, SLI, ageing index, afro-descendant per 100 inhabitants, indigenous language-speaking per 100 inhabitants, affiliation to health services per 100 inhabitants, members per household, hospitals per 10 000 inhabitants, hospital beds per 10 000 inhabitants. (c) Risk of pneumonia, model adjusted by sex, age and time from symptom onset to care, SLI, ageing index, afro-descendant per 100 inhabitants, indigenous language-speaking per 100 inhabitants, affiliation to health services per 100 inhabitants, members per household, hospitals per 10 000 inhabitants, hospital beds per 10 000 inhabitants. (d) Risk of admission to ICU, model adjusted by sex, age, and time from symptom onset to care, SLI, ageing index, afro-descendant per 100 inhabitants, indigenous language-speaking per 100 inhabitants, affiliation to health services per 100 inhabitants, members per household, hospitals per 10 000 inhabitants, hospital beds per 10 000 inhabitants. CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; Immunosupp, immunosuppression; ICU, intensive care unit; IMV, invasive mechanical ventilation.